Related Experiment Video
Updated: Jun 10, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Carbon monoxide suppresses membrane expression of TLR4 via myeloid differentiation factor-2 in betaTC3 cells
Fredy Rocuts1, Yinghua Ma, Xinyu Zhang
1Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Abstract:
Islet allografts from donor mice exposed to CO are protected from immune rejection after transplantation via the suppression of membrane trafficking/activation of TLR4 in islets/beta cells. The molecular mechanisms of how CO suppresses TLR4 activation in beta cells remain unclear and are the focus of this study. Cells of the insulinoma cell line, betaTC3, were stably transfected with pcDNA3-TLR4-YFP and pDsRed-Monomer-Golgi plasmids and used to identify the subcellular distribution of TLR4 before and after LPS stimulation by confocal microscopy. Immunofluorescence analysis revealed that TLR4 mainly resides in the Golgi apparatus in betaTC3 cells when in a quiescent state. LPS stimulation led to a rapid trafficking of TLR4 from the Golgi to the cell membrane. Physical interaction between TLR4 and myeloid differentiation factor-2 (MD-2) was confirmed by immunoprecipitation. Depleting MD-2 using small interfering RNA or blocking the N-glycosylation of cells using tunicamycin blocked membrane trafficking of TLR4. Pre-exposing cells to CO at a concentration of 250 parts per million suppressed membrane trafficking of TLR4 via inhibiting its glycosylation and the interaction between TLR4 and MD-2. In conclusion, MD-2 is required for the glycosylation of TLR4 and its consequent membrane trafficking in betaTC3 cells. CO suppresses membrane activation of TLR4 via blocking its glycosylation and the physical interaction between TLR4 and MD-2.
Insights
Carbon monoxide (CO) protects transplanted islets from rejection by suppressing Toll-like receptor 4 (TLR4) activation in beta cells. CO inhibits TLR4 glycosylation and its interaction with MD-2, preventing membrane trafficking and activation.
Area of Science:
- Immunology
- Cell Biology
- Transplantation Biology
Background:
- Islet allografts face immune rejection after transplantation.
- Carbon monoxide (CO) exposure protects transplanted islets by suppressing Toll-like receptor 4 (TLR4) activation in beta cells.
- The precise molecular mechanisms by which CO modulates TLR4 in beta cells are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying CO-mediated suppression of TLR4 activation in beta cells.
- To investigate the role of TLR4 trafficking and its interaction with MD-2 in beta cells.
- To determine how CO affects TLR4 glycosylation and membrane localization.
Main Methods:
- Utilized betaTC3 insulinoma cells stably transfected with TLR4-YFP and Golgi markers.
- Employed confocal microscopy to track subcellular TLR4 distribution.
- Confirmed TLR4 and MD-2 interaction using immunoprecipitation.
- Investigated the effects of MD-2 depletion and tunicamycin treatment on TLR4 trafficking.
- Assessed CO's impact on TLR4 glycosylation and membrane trafficking.
Main Results:
- In quiescent betaTC3 cells, TLR4 predominantly localized to the Golgi apparatus.
- LPS stimulation induced rapid TLR4 trafficking from the Golgi to the cell membrane.
- MD-2 depletion or N-glycosylation inhibition blocked TLR4 membrane translocation.
- CO pre-exposure (250 ppm) inhibited TLR4 glycosylation and its interaction with MD-2, suppressing membrane trafficking.
- CO effectively blocked LPS-induced TLR4 membrane activation.
Conclusions:
- Myeloid differentiation factor-2 (MD-2) is essential for TLR4 glycosylation and subsequent membrane trafficking in beta cells.
- Carbon monoxide (CO) inhibits beta cell TLR4 activation by preventing its glycosylation and blocking the TLR4-MD-2 interaction.
- These findings provide insights into CO's protective effects against islet transplant rejection.
Related Concept Videos
Master Transcription Regulators
Co-activators and Co-repressors
General Transcription Factors
TGF - β Signaling Pathway
